化学
热休克蛋白90
三环
热休克蛋白
结构-活动关系
伴侣(临床)
立体化学
药物发现
虚拟筛选
铅化合物
结合位点
小分子
IC50型
生物化学
组合化学
体外
医学
病理
基因
作者
François Vallée,Chantal Carrez,Fabienne Pilorge,Alain Dupuy,Annick Parent,Luc Bertin,Fabienne Thompson,Paul Ferrari,Florence Fassy,Annabelle Lamberton,Anne Thomas,Rosalía Arrebola,Stéphane Guerif,Alexandre Rohaut,Victor Certal,Jean-Marie Ruxer,Cécile Delorme,Alain Jouanen,Jacques Dumas,Claudine Grépin
摘要
A novel class of heat shock protein 90 (Hsp90) inhibitors was developed after a low throughput screen (LTS) of a focused library containing approximately 21K compounds selected by virtual screening. The initial [1-{3-H-imidazo[4-5-c]pyridin-2-yl}-3,4-dihydro-2H-pyrido[2,1-a]isoindole-6-one] (1) compound showed moderate activity (IC(50) = 7.6 μM on Hsp82, the yeast homologue of Hsp90). A high-resolution X-ray structure shows that compound 1 binds into an "induced" hydrophobic pocket, 10-15 Å away from the ATP/resorcinol binding site. Iterative cycles of structure-based drug design (SBDD) and chemical synthesis led to the design and preparation of analogues with improved affinity. These optimized molecules make productive interactions within the ATP binding site as reported by other Hsp90 inhibitors. This resulted in compound 8, which is a highly potent inhibitor in biochemical and cellular assays (K(d) = 0.35 nM on Hsp90; IC(50) = 30 nM on SKBr3 mammary carcinoma cells) and in an in vivo leukemia model.
科研通智能强力驱动
Strongly Powered by AbleSci AI